Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of 3,5-Dihydroxybenzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 1/20 | 0.55 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.45 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 5/20 | 0.94 |
| ▸ | CA1 | P00915 | 5/20 | 0.94 |
| ▸ | CA2 | P00918 | 5/20 | 0.94 |
| ▸ | CA9 | Q16790 | 5/20 | 0.94 |
| ▸ | CA7 | P43166 | 4/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.94 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.65 |
| ▸ | CA5A | P35218 | 3/20 | 0.55 |
| ▸ | CA6 | P23280 | 3/20 | 0.55 |
| ▸ | CA3 | P07451 | 2/20 | 0.55 |
| ▸ | CA4 | P22748 | 2/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,5-Dihydroxybenzoic Acid SCHEMBL28106 | 0.97 | CA12 (1.00) | CA12CA1CA2CA9CA7 | |
| 3,5-Dihydroxybenzoic Acid SCHEMBL618767 | 0.97 | CA12 (1.00) | CA12CA1CA2CA9CA7 | |
| 3,5-Dihydroxybenzoic Acid SCHEMBL10936753 | 0.94 | CA12 (0.94) | CA12CA1CA2CA9CA7 | |
| 3,5-Dihydroxybenzoic Acid SCHEMBL1151737 | 0.94 | CA12 (0.94) | CA12CA1CA2CA9CA7 | |
| 3,5-Dihydroxybenzoic Acid SCHEMBL9693437 | 0.94 | CA12 (0.94) | CA12CA1CA2CA9CA7 | |
| 3,5-Dihydroxybenzoic Acid SCHEMBL5695849 | 0.94 | CA12 (0.94) | CA12CA1CA2CA9CA7 | |
| SCHEMBL139644 | 0.91 | CA12 (0.88) | CA12CA1CA2CA9CA7 | |
| Phloroglucinol SCHEMBL21465836 | 0.91 | CA12 (0.88) | CA12CA1CA2CA9CA7 | |
| SCHEMBL9178343 | 0.88 | CA12 (0.83) | CA12CA1CA2CA9CA7 | |
| Methane SCHEMBL6131088 | 0.88 | CA12 (0.83) | CA12CA1CA2CA9CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121652109-A | Aripiprazole-3, 5-dihydroxybenzoic acid-hydrate crystal form and preparation method thereof | 鲁南制药集团股份有限公司 | 2026-03-13 | — | — | CN | disclosed |
| CN-121652109-A | Aripiprazole-3, 5-dihydroxybenzoic acid-hydrate crystal form and preparation method thereof | 鲁南制药集团股份有限公司 | 2026-03-13 | — | — | CN | disclosed |
| CN-121574093-A | Aripiprazole-2, 3-dihydroxybenzoic acid-hydrate crystal form and preparation method thereof | 鲁南制药集团股份有限公司 | 2026-02-27 | — | — | CN | disclosed |